{
    "id": 29537,
    "fullName": "BCL2 G101V",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "BCL2 G101V lies within the BH3 motif of the Bcl2 protein (UniProt.org). G101V has been associated with BCL2 inhibitor resistance (PMID: 30514704, PMID: 31160589), but has not been biochemically characterized and therefore, its effect on Bcl2 protein function is unknown (PubMed, Mar 2020).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 14412,
                    "pubMedId": 30514704,
                    "title": "Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30514704"
                },
                {
                    "id": 15287,
                    "pubMedId": 31160589,
                    "title": "Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31160589"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 596,
        "geneSymbol": "BCL2",
        "terms": [
            "BCL2",
            "Bcl-2",
            "PPP1R50"
        ]
    },
    "variant": "G101V",
    "createDate": "03/07/2019",
    "updateDate": "03/27/2020",
    "referenceTranscriptCoordinates": {
        "id": 178858,
        "transcript": "NM_000633",
        "gDna": "chr18:g.63318365C>A",
        "cDna": "c.302G>T",
        "protein": "p.G101V",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16272,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells collected post-Venclexta (venetoclax) progression from chronic lymphocytic leukemia patients that were found to harbor BCL2 G101V demonstrated decreased sensitivity to ABT-737 in culture compared to cells collected prior to progression (PMID: 30514704).",
            "molecularProfile": {
                "id": 31579,
                "profileName": "BCL2 G101V"
            },
            "therapy": {
                "id": 1772,
                "therapyName": "ABT-737",
                "synonyms": null
            },
            "indication": {
                "id": 1040,
                "name": "chronic lymphocytic leukemia",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 14412,
                    "pubMedId": 30514704,
                    "title": "Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30514704"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 17576,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BCL2 G101V conferred resistance to BCL201 (S55746) in cultured B-cells (PMID: 31160589).",
            "molecularProfile": {
                "id": 31579,
                "profileName": "BCL2 G101V"
            },
            "therapy": {
                "id": 6414,
                "therapyName": "BCL201",
                "synonyms": null
            },
            "indication": {
                "id": 707,
                "name": "B-cell lymphoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 15287,
                    "pubMedId": 31160589,
                    "title": "Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31160589"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16271,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, BCL2 G101V was identified as a recurrent mutation in post-progression samples from a cohort of chronic lymphocytic leukemia patients treated with Venclexta (venetoclax), appearing in 7 of 15 patients, and patient cells harboring BCL2 G101V demonstrated decreased sensitivity to Venclexta (venetoclax) in culture (PMID: 30514704).",
            "molecularProfile": {
                "id": 31579,
                "profileName": "BCL2 G101V"
            },
            "therapy": {
                "id": 1562,
                "therapyName": "Venetoclax",
                "synonyms": null
            },
            "indication": {
                "id": 1040,
                "name": "chronic lymphocytic leukemia",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 14412,
                    "pubMedId": 30514704,
                    "title": "Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30514704"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31579,
            "profileName": "BCL2 G101V",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 178859,
            "transcript": "XM_017025917",
            "gDna": "chr18:g.63318365C>A",
            "cDna": "c.302G>T",
            "protein": "p.G101V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 178860,
            "transcript": "XM_011526135",
            "gDna": "chr18:g.63318365C>A",
            "cDna": "c.302G>T",
            "protein": "p.G101V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 178861,
            "transcript": "NM_000657",
            "gDna": "chr18:g.63318365C>A",
            "cDna": "c.302G>T",
            "protein": "p.G101V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 178858,
            "transcript": "NM_000633",
            "gDna": "chr18:g.63318365C>A",
            "cDna": "c.302G>T",
            "protein": "p.G101V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}